Board of Directors
News & Events
Investors & Partnering
Why invest in SolAeroMed
Recruiting CF Patients
Now Recruiting CF Patients
SolAeroMed S-1226 COVID-19 Media Room
<a href="https://www.solaeromed.com/logo-image/">Logo Image</a>
SolAeroMed is promoting a new S1226 Phase II trial in Cystic Fibrosis
March 15, 2019 A Scientific Poster was presented at a University of Calgary event in Q1 2019
S1226 Portable Delivery Advanced Design Concept
We have now completed a $150,000 grant with Calgary based SAIT, which build on the earlier work by Melbourne based Hydrix. The result is a more advanced design...
Treatment of Acute Asthma in the ICU
In October 2017 we were able to treat a severely ill asthmatic patient in Calgary ICU with our experimental S1226 drug. Results were in the words of the...